SCHEMBL4484319

SCHEMBL4484319

Cc1ccnc(C)c1-c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 11/20 0.53
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP1A2 P05177 1/20 0.50
KDM4E B2RXH2 2/20 0.47
HTT P42858 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
CYP2E1 P05181 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2B6 P20813 2/20 0.46
CYP2C19 P33261 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29912818 1.00 CYP2A6 (0.53) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL16056691 0.86 KDM4E (0.48) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL21476509 0.80 CYP2A6 (0.60) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL27564359 0.80 NPC1 (0.46) CYP2A6HSP90AA1MAPTGAAHPGD
SCHEMBL30702237 0.79 MKNK1 (0.59) CYP2A6CYP3A4CYP1A2MKNK1MKNK2
SCHEMBL30702229 0.79 MKNK1 (0.59) CYP2A6CYP3A4CYP1A2MKNK1MKNK2
SCHEMBL27586450 0.76 NUDT1 (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL28313349 0.76 PIK3CA (0.51) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL16099185 0.76 RXFP1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E
SCHEMBL28242608 0.75 CYP2A6 (0.47) CYP2A6CYP3A4ALDH1A1CYP1A2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP CYP2A6 108/4885CYP3A4 5/4885ALDH1A1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.